Adults with poor mental health report worse self-rated overall health and more chronic illness, according to a study.

The FDA granted Priority Review to the novel Factor XIa inhibitor asundexian for secondary stroke prevention following an ischemic stroke.

A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis.

A single-shot nanosecond pulsed field ablation catheter safely achieves high rates of acute and durable pulmonary vein isolation in PAF.

Researchers evaluated whether atrial fibrillation increases the risk for mechanical ventilation among patients with acute mesenteric ischemia.

An American doctor who was exposed to Ebola while working in the Democratic Republic of the Congo (DRC) has tested positive for the disease.

New-onset atrial fibrillation (AF) may accelerate kidney function decline, according to results of a new study.

Ensitrelvir administered within 72 hours of symptom onset in the index patient is effective for preventing COVID-19.

A clinical decision support system (CDSS) for CKD does not improve physician behavior or patient outcomes over a control intervention.

Postoperative step count following surgery is associated with reductions in length of stay, complications, and readmissions.

Post-stroke employment rates are significantly lower for Black survivors than White survivors despite adjustments for baseline health.

The FDA approved the aldosterone synthase inhibitor Baxfendy (baxdrostat) for adults with inadequately controlled hypertension.